💙 🔷 Not impressed by Big Tech in Q3? Explore these Blue Chip Bargains insteadUnlock them all

BRIEF-Strategic partner Intega Skin Sciences Inc,acquired by Crescita Therapeutics Inc

Published 2016-09-01, 10:57 a/m
© Reuters.  BRIEF-Strategic partner Intega Skin Sciences Inc,acquired by Crescita Therapeutics Inc

Sept 1 (Reuters) - Knight Therapeutics Inc

* As part of Crescita acquisition, it was agreed that $3.0 million of Knight's secured loan will be repaid

* As part of Crescita deal , it was agreed that interest rate on Knight's remaining loan balance will be reduced to 9%/year

* Received 645,002 common shares of Crescita in exchange for its intega shares

* Now owns an aggregate of 1.5 million common shares of crescita, representing about 10.9% of outstanding common shares of Crescita

* Strategic partner Intega Skin Sciences Inc, a Montreal-based Dermatology Company, has been acquired by Crescita Therapeutics Inc Source text for Eikon: ID:nCCN8QF7qj

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.